Advanced Filters
noise

depression Clinical Trials

A listing of depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,259 clinical trials
M Margot Paul, PsyD

Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression

The primary aims of this study are to assess the feasibility, acceptability, and tolerability of using an immersive virtual reality (VR) headset to engage in behavioral activation (BA) for older adults diagnosed with major depressive disorder (MDD). The secondary aim of this study is to explore the efficacy of using …

65 years of age All Phase N/A

Vitamin B6 and Depression in Pregnant and Peri-partum Women

Perinatal depression is a highly prevalent and serious health issue during pregnancy. According to statistics, approximately one out of every ten postpartum women experiences this condition. Symptoms can manifest as mood fluctuations or emotional lows. Unfortunately, these symptoms are often overlooked by patients themselves or misinterpreted by others as normal …

20 - 50 years of age Female Phase N/A
D Dorjee Bargeman

Powerly - Science-based Digital Intervention Preventing Postpartum Depression and Anxiety

The goal of this clinical trial is to determine if the Powerly app can help prevent postpartum depression and anxiety in healthy pregnant women. The main questions it aims to answer are: Does the Powerly app reduce postpartum depression and anxiety? Does it improve emotion regulation and maternal bonding with …

18 years of age Female Phase N/A
M Metin Çınaroğlu, Phd

EFCT Vs. BCT for Depression and Anxiety in Married Couples

This study compares the effectiveness of Emotion-Focused Couples Therapy (EFCT) and Behavioral Couples Therapy (BCT) in reducing depression and anxiety symptoms in married couples. A total of 150 married couples aged 18-65 will be screened, and 60 couples with high depression and anxiety levels will be selected. These couples will …

18 - 65 years of age All Phase N/A
A Alex Coles, MSc

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

Psilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. The purpose of this study is to assess the feasibility, tolerability, and preliminary efficacy of psilocybin therapy for adults with chronic neuropathic pain and co-morbid treatment …

18 - 65 years of age All Phase 2
J Jill Cumby, RN

Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use

Severe mental illness (SMI) refers to the most burdensome psychiatric conditions. The need to pre-empt the onset of SMI is pressing because once SMI develops, quality of life is poor and available treatments have limited efficacy. Most risk factors for SMI are either unchangeable (e.g., genetics) or difficult to alter …

12 - 21 years of age All Phase N/A
A Allison Johnson

Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors

Conditions treated in intensive care units (ICUs) such as the acute respiratory distress syndrome (ARDS), congestive heart failure, COVID pneumonia, and sepsis are common. These can lead to high rates of depression, anxiety, and PTSD that worsen quality of life. Yet there are few effective strategies able to overcome barriers …

18 years of age All Phase N/A
H Huibert Burger, MD PhD

Lifestyle InterVEntion Study in General Practice: LIVES - GP

Patients with depression are at a substantially increased risk of chronic physical disease including cardiovascular disease. This may be attributed primarily to an unhealthy lifestyle related to their disorder. Interestingly, the unhealthy lifestyle feeds back to decreased quality of life and increased depressive symptoms, thus creating a hazardous vicious circle. …

18 years of age All Phase N/A
Y Yolanda Cañada, MD

Efficacy and Biomarkers of Response of TBS in Treatment Resistant Depression

Theta Burst Transcranial Magnetic Stimulation (TBS) in dorsolateral prefrontal cortex (DLPFC) has shown efficacy and safety as an adjuvant strategy for resistant to treatment depression (RTD) in daily sessions during 4-6 weeks (20-30 sessions). Current investigation in TBS aims to design intensive treatment protocols so as to achieve earlier responses …

18 - 70 years of age All Phase N/A
N Nana B. Sørensen, MD

T-PEMF Headband Stimulation for Patients With Moderate to Servere Depression

This study is a blinded 8-week, randomized trial conducted to clarify whether treatment with brain stimulation for half an hour daily for eight weeks with a headband with weak pulsating electromagnetic fields (T-PEMF) can achieve a safe effect on depression compared to the same treatment with a placebo T-PEMF.

18 - 65 years of age All Phase N/A

Simplify language using AI